CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 4 Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chf Scientific Operations Off sold 21,224 shares at $4.53 ($96,145)
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Grant or award CEO and President acquired 65,000 shares (grant or award)
- 4 Grant or award Chf Scientific Operations Off acquired 24,500 shares (grant or award)
- 4 Grant or award VP, Controller acquired 9,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 23,500 shares (grant or award)
- 4 Shares withheld for taxes CEO and President gave up 15,469 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,061 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Controller gave up 2,130 shares (to pay taxes)
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 6,554 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 6,479 shares (to pay taxes)
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 2,157 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Controller gave up 394 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 158,901 shares at an average $1.71 ($271,715)
- 4 Open-market sale 10% owner sold 61,992 shares at an average $1.84 ($114,251)
Page 3 of 20 · 382 filings